Literature search services are currently unavailable. During our hosting provider's UPS upgrade we experienced a hardware failure and are currently working to resolve the issue.

Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.

The HIV-1 broadly neutralizing Ab (bnAb) 2F5 has been shown to be poly-/self-reactive in vitro, and we previously demonstrated that targeted expression of its VDJ rearrangement alone was sufficient to trigger a profound B cell developmental blockade in 2F5 V(H) knockin (KI) mice, consistent with central deletion of 2F5 H chain-expressing B cells. In this study, we generate a strain expressing the entire 2F5 bnAb specificity, 2F5 V(H) × V(L) KI mice, and find an even higher degree of tolerance control than observed in the 2F5 V(H) KI strain. Although B cell development was severely impaired in 2F5 V(H) × V(L) KI animals, we demonstrate rescue of their B cells when cultured in IL-7/BAFF. Intriguingly, even under these conditions, most rescued B cell hybridomas produced mAbs that lacked HIV-1 Envelope (Env) reactivity due to editing of the 2F5 L chain, and the majority of rescued B cells retained an anergic phenotype. Thus, when clonal deletion is circumvented, κ editing and anergy are additional safeguards preventing 2F5 V(H)/V(L) expression by immature/transitional B cells. Importantly, 7% of rescued B cells retained 2F5 V(H)/V(L) expression and secreted Env-specific mAbs with HIV-1-neutralizing activity. This partial rescue was further corroborated in vivo, as reflected by the anergic phenotype of most rescued B cells in 2F5 V(H) × V(L) KI × Eμ-Bcl-2 transgenic mice and significant (yet modest) enrichment of Env-specific B cells and serum Igs. The rescued 2F5 mAb-producing B cell clones in this study are the first examples, to our knowledge, of in vivo-derived bone marrow precursors specifying HIV-1 bnAbs and provide a starting point for design of strategies aimed at rescuing such B cells.

Pubmed ID: 21908739


  • Verkoczy L
  • Chen Y
  • Bouton-Verville H
  • Zhang J
  • Diaz M
  • Hutchinson J
  • Ouyang YB
  • Alam SM
  • Holl TM
  • Hwang KK
  • Kelsoe G
  • Haynes BF


Journal of immunology (Baltimore, Md. : 1950)

Publication Data

October 1, 2011

Associated Grants

  • Agency: NIAID NIH HHS, Id: AI067854
  • Agency: NIAID NIH HHS, Id: AI081579
  • Agency: NIAID NIH HHS, Id: AI087202
  • Agency: NIAID NIH HHS, Id: R01 AI081579
  • Agency: NIAID NIH HHS, Id: R01 AI087202
  • Agency: NIAID NIH HHS, Id: R01 AI087202-01

Mesh Terms

  • Animals
  • Antibodies, Neutralizing
  • B-Lymphocytes
  • Cell Separation
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Gene Knock-In Techniques
  • Genes, Immunoglobulin
  • HIV Infections
  • HIV-1
  • Immune Tolerance
  • Immunoglobulin Variable Region
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic